At the moment, the recommended treatment for COPD in Europe is an inhaled corticosteroid (ICS), a long-acting beta-agonist (LABA) and long-acting muscarinic antagonist (LAMA), or LABA/LAMA dual ...

Moreover, 15% of them were taking LAMA or LABA therapies in combination with inhaled corticosteroids ... company's lead drug candidate into the large COPD market in late 2023 or 2024.

The Spanish COPD guidelines recommend treatment ... a long-acting muscarinic receptor antagonists (LAMA) to ICS + long-acting b2 agonist (LABA) combination for 'triple therapy'.

People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...

There are certain risk factors for COPD, including obesity and having type 2 diabetes. A new study has found that people who have type 2 diabetes who are treated with GLP-1 and SGLT-2 medications ...

Individuals with asthma and chronic obstructive pulmonary disease (COPD) were more vulnerable than healthy controls to ...

Lyn Iemma, aged 75 years at the time of writing, would not describe her life as dramatic. Born and raised in Perth, WA, Australia, this thriving but relaxed city is the place she has always called ...

The death of Gyalo Thondup, elder brother to the 14th Dalai Lama and a prominent figure among exiled Tibetans, marks the “the end of an era” for attempted negotiations between Dharamsala and ...

Fourteen organizations representing Indigenous peoples and local communities across Central and South America submitted recommendations to Architecture for REDD+ Transactions (ART) to demand ...